Read Time:7 Second
The FDA plans to call a last-minute meeting of its outside advisors to further review the Eli Lilly Alzheimer’s treatment’s safety and efficacy.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
